Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Fulminant Acanthamoeba castellanii Encephalitis in an Ibrutinib-Treated Patient.

Crothers JW, Hsu L, Marty FM.

Open Forum Infect Dis. 2020 Jan 20;7(2):ofaa025. doi: 10.1093/ofid/ofaa025. eCollection 2020 Feb.

2.

A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract.

Marty FM, Chemaly RF, Mullane KM, Lee DG, Hirsch HH, Small CB, Bergeron A, Shoham S, Ljungman P, Waghmare A, Blanchard E, Kim YJ, McKevitt M, Porter DP, Jordan R, Guo Y, German P, Boeckh M, Watkins TR, Chien JW, Dadwal SS.

Clin Infect Dis. 2019 Dec 3. pii: ciz1167. doi: 10.1093/cid/ciz1167. [Epub ahead of print]

PMID:
31915807
3.

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation.

Marty FM, Ljungman PT, Chemaly RF, Wan H, Teal VL, Butterton JR, Yeh WW, Leavitt RY, Badshah CS.

Am J Transplant. 2019 Dec 28. doi: 10.1111/ajt.15764. [Epub ahead of print]

PMID:
31883426
4.

A phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients.

Chemaly RF, Dadwal SS, Bergeron A, Ljungman P, Kim YJ, Cheng GS, Pipavath SN, Limaye AP, Blanchard E, Winston DJ, Stiff PJ, Zuckerman T, Lachance S, Rahav G, Small CB, Mullane KM, Patron RL, Lee DG, Hirsch HH, Waghmare A, McKevitt M, Jordan R, Guo Y, German P, Porter DP, Gossage DL, Watkins TR, Marty FM, Chien JW, Boeckh M.

Clin Infect Dis. 2019 Dec 3. pii: ciz1166. doi: 10.1093/cid/ciz1166. [Epub ahead of print]

PMID:
31793991
5.

Invasive Fungal Carotiditis: A Rare Manifestation of Cranial Invasive Fungal Disease: Case Series and Systematic Review of the Literature.

Little JS, Cheng MP, Hsu L, Corrales CE, Marty FM.

Open Forum Infect Dis. 2019 Sep 5;6(10):ofz392. doi: 10.1093/ofid/ofz392. eCollection 2019 Oct.

6.

Development of a Set of Lupus-Specific Ambulatory Care Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study.

Feldman CH, Speyer C, Ashby R, Bermas B, Bhattacharyya S, Chakravarty E, Everett B, Ferucci E, Hersh AO, Marty FM, Merola JF, Ramsey-Goldman R, Rovin BH, Son MB, Tarter L, Waikar S, Yazdany J, Weissman JS, Costenbader KH.

Arthritis Care Res (Hoboken). 2019 Oct 18. doi: 10.1002/acr.24095. [Epub ahead of print]

PMID:
31628721
7.

Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system.

Schwartz S, Cornely OA, Hamed K, Marty FM, Maertens J, Rahav G, Herbrecht R, Heinz WJ.

Med Mycol. 2019 Oct 15. pii: myz103. doi: 10.1093/mmy/myz103. [Epub ahead of print]

PMID:
31613363
8.

Case 31-2019: A 45-Year-Old Woman with Headache and Somnolence.

Tunkel AR, Baron EL, Buch KA, Marty FM, Martinez-Lage M.

N Engl J Med. 2019 Oct 10;381(15):1459-1470. doi: 10.1056/NEJMcpc1904045. No abstract available.

PMID:
31597024
9.

Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis.

Cheng MP, Orejas JL, Arbona-Haddad E, Bold TD, Solomon IH, Chen K, Pandit A, Kusztos AE, Cummins KC, Liakos A, Marty FM, Koo S, Hammond SP.

Mycoses. 2020 Jan;63(1):58-64. doi: 10.1111/myc.13013. Epub 2019 Oct 30.

PMID:
31587405
10.

Reply to Singh.

Bold TD, Cheng MP, Marty FM.

Clin Infect Dis. 2019 Oct 4. pii: ciz981. doi: 10.1093/cid/ciz981. [Epub ahead of print] No abstract available.

PMID:
31584622
11.

Long-term Persistence of an Extensively Drug Resistant Subclade of Globally Distributed Pseudomonas aeruginosa Clonal Complex 446 in an Academic Medical Center.

Pincus NB, Bachta KER, Ozer EA, Allen JP, Pura ON, Qi C, Rhodes NJ, Marty FM, Pandit A, Mekalanos JJ, Oliver A, Hauser AR.

Clin Infect Dis. 2019 Oct 4. pii: ciz973. doi: 10.1093/cid/ciz973. [Epub ahead of print]

PMID:
31583403
12.

Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.

Schneeweiss S, Carver PL, Datta K, Galar A, Johnson MD, Letourneau AR, Marty FM, Nagel J, Najdzinowicz M, Saul M, Schuster M, Shoham S, Silveira FP, Varughese C, Wilck M, Weatherby L, Oene JV, Walker AM.

J Antimicrob Chemother. 2020 Jan 1;75(1):221-228. doi: 10.1093/jac/dkz396.

PMID:
31580432
13.

Herpes Zoster Subunit Vaccination for Renal Transplant Recipients.

Cheng MP, Quach C, Marty FM.

Clin Infect Dis. 2020 Feb 3;70(4):718-719. doi: 10.1093/cid/ciz494. No abstract available.

PMID:
31504313
14.

Draft Genome Sequence of Pseudomonas aeruginosa Strain BWH047, a Sequence Type 235 Multidrug-Resistant Clinical Isolate Expressing High Levels of Colistin Resistance.

Bachta KER, Ozer EA, Pandit A, Marty FM, Mekalanos JJ, Hauser AR.

Microbiol Resour Announc. 2019 Jul 18;8(29). pii: e00623-19. doi: 10.1128/MRA.00623-19.

15.

Reply to Aronson et al.

Cheng MP, Marty FM.

Clin Infect Dis. 2019 Jul 11. pii: ciz595. doi: 10.1093/cid/ciz595. [Epub ahead of print] No abstract available.

PMID:
31297517
16.

Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and increase of T regulatory cells.

Karantanos T, Kim HT, Tijaro-Ovalle NM, Li L, Cutler C, Antin JH, Ballen K, Marty FM, Tan CS, Ritz J, Politikos I, Boussiotis V.

Clin Immunol. 2019 Oct;207:18-23. doi: 10.1016/j.clim.2019.06.010. Epub 2019 Jun 27.

PMID:
31255803
17.

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-Seropositive Recipients of Allogeneic Hematopoietic-Cell Transplantation.

Ljungman P, Schmitt M, Marty FM, Maertens J, Chemaly RF, Kartsonis NA, Butterton JR, Wan H, Teal VL, Sarratt K, Murata Y, Leavitt RY, Badshah C.

Clin Infect Dis. 2019 Jun 8. pii: ciz490. doi: 10.1093/cid/ciz490. [Epub ahead of print]

PMID:
31179485
18.

Five-Year Follow-up after Face Transplantation.

Tasigiorgos S, Kollar B, Turk M, Perry B, Alhefzi M, Kiwanuka H, Nizzi MC, Marty FM, Chandraker A, Tullius SG, Riella LV, Pomahac B.

N Engl J Med. 2019 Jun 27;380(26):2579-2581. doi: 10.1056/NEJMc1810468. Epub 2019 May 29. No abstract available.

PMID:
31141626
19.

Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?

Nucci M, Shoham S, Abdala E, Hamerschlak N, Rico JC, Forghieri F, Nouér SA, Cappellano P, Solza C, Gonzaga Y, Nadali G, Nucci F, Colombo AL, Albuquerque AM, Queiroz-Telles Filho F, Lima CBL, Arrais-Rodrigues C, Rocha V, Marty FM.

Mycoses. 2019 May;62(5):413-417. doi: 10.1111/myc.12901.

PMID:
30720902
20.

Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation.

Cheng MP, Kusztos AE, Bold TD, Ho VT, Glotzbecker BE, Hsieh C, Baker MA, Baden LR, Hammond SP, Marty FM.

Clin Infect Dis. 2019 Aug 16;69(5):869-872. doi: 10.1093/cid/ciz048.

PMID:
30689792
21.

Authors' Response.

Cheng MP, Marty FM, Costa DB, Awad MM.

J Thorac Oncol. 2018 Nov;13(11):e237. doi: 10.1016/j.jtho.2018.09.015. No abstract available.

22.

Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.

Papanicolaou GA, Silveira FP, Langston AA, Pereira MR, Avery RK, Uknis M, Wijatyk A, Wu J, Boeckh M, Marty FM, Villano S.

Clin Infect Dis. 2019 Apr 8;68(8):1255-1264. doi: 10.1093/cid/ciy706.

23.

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.

Marty FM, Winston DJ, Chemaly RF, Mullane KM, Shore TB, Papanicolaou GA, Chittick G, Brundage TM, Wilson C, Morrison ME, Foster SA, Nichols WG, Boeckh MJ; SUPPRESS Trial Clinical Study Group.

Biol Blood Marrow Transplant. 2019 Feb;25(2):369-381. doi: 10.1016/j.bbmt.2018.09.038. Epub 2018 Oct 4.

24.

Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation.

Chen K, Cheng MP, Hammond SP, Einsele H, Marty FM.

Blood Adv. 2018 Aug 28;2(16):2159-2175. doi: 10.1182/bloodadvances.2018016493. Review.

25.

Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib.

Cummins KC, Cheng MP, Kubiak DW, Davids MS, Marty FM, Issa NC.

Leuk Lymphoma. 2019 Feb;60(2):527-530. doi: 10.1080/10428194.2018.1485913. Epub 2018 Jul 24. No abstract available.

PMID:
30037292
26.

Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection.

Scully EP, Rutishauser RL, Simoneau CR, Delagrèverie H, Euler Z, Thanh C, Li JZ, Hartig H, Bakkour S, Busch M, Alter G, Marty FM, Wang CC, Deeks SG, Lorch J, Henrich TJ.

Ann Oncol. 2018 Oct 1;29(10):2141-2142. doi: 10.1093/annonc/mdy259. No abstract available.

27.

Cytomegalovirus Infection Among Cord Blood Allogeneic Transplantation Recipients: Low Incidence of Cytomegalovirus Events without High-Dose Valacyclovir Prophylaxis.

Knoll BM, Peixoto D, Koo S, Hammond SP, Ho VT, Antin JH, Soiffer RJ, Cutler C, Marty FM.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2164-2165. doi: 10.1016/j.bbmt.2018.06.029. Epub 2018 Jun 30. No abstract available.

28.

Case 5-2018: A Man with Confusion after Stem-Cell Transplantation.

Hill JA, Myerson D, Marty FM.

N Engl J Med. 2018 Jun 28;378(26):2544-5. doi: 10.1056/NEJMc1806522. No abstract available.

PMID:
29952184
29.

NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation.

Hogan LE, Körner C, Hobbs K, Simoneau CR, Thanh C, Gibson EA, Palmer CD, Pandit A, Marty FM, Kuritzkes DR, Jost S, Ritz J, Henrich TJ.

Blood Adv. 2018 Jun 26;2(12):1412-1416. doi: 10.1182/bloodadvances.2018016329. No abstract available.

30.

Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation.

Cheng MP, Pandit A, Antin JH, Walsh SR, Huynh D, Ghobrial IM, Baden LR, Marty FM, Issa NC.

Blood Adv. 2018 Jun 12;2(11):1272-1276. doi: 10.1182/bloodadvances.2018018911. Erratum in: Blood Adv. 2018 Jul 10;2(13):1541.

31.

Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.

Hogan LE, Hanhauser E, Hobbs KS, Palmer CD, Robles Y, Jost S, LaCasce AS, Abramson J, Hamdan A, Marty FM, Kuritzkes DR, Henrich TJ.

PLoS One. 2018 May 10;13(5):e0197298. doi: 10.1371/journal.pone.0197298. eCollection 2018.

32.

Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer.

Ostios-Garcia L, Faig J, Leonardi GC, Adeni AE, Subegdjo SJ, Lydon CA, Rangachari D, Huberman MS, Sehgal K, Shea M, VanderLaan PA, Cheng MP, Marty FM, Hammond SP, Costa DB, Awad MM.

J Thorac Oncol. 2018 Jul;13(7):1037-1042. doi: 10.1016/j.jtho.2018.03.031. Epub 2018 Apr 6.

33.

Isavuconazole for treatment of rare invasive fungal diseases.

Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Perfect JR, Oren I, Schmitt-Hoffmann AH, Giladi M, Marty FM, Rahav G.

Mycoses. 2018 Aug;61(8):518-533. doi: 10.1111/myc.12778.

PMID:
29611246
34.

Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.

Marty FM, Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Oren I, Schmitt-Hoffmann AH, Giladi M, Rahav G, Perfect JR.

Mycoses. 2018 Jul;61(7):485-497. doi: 10.1111/myc.12777. Epub 2018 Apr 26.

PMID:
29611227
35.

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.

Perfect JR, Cornely OA, Heep M, Ostrosky-Zeichner L, Mullane KM, Maher R, Croos-Dabrera R, Lademacher C, Engelhardt M, Chen C, Marty FM.

Mycoses. 2018 Jul;61(7):420-429. doi: 10.1111/myc.12769. Epub 2018 Apr 19. Review.

36.

Letermovir Prophylaxis for Cytomegalovirus.

Marty FM, Maertens J, Badshah C.

N Engl J Med. 2018 Mar 8;378(10):965. doi: 10.1056/NEJMc1800572. No abstract available.

PMID:
29514025
37.

Risk of hepatitis B virus reactivation in patients treated with ibrutinib.

Hammond SP, Chen K, Pandit A, Davids MS, Issa NC, Marty FM.

Blood. 2018 Apr 26;131(17):1987-1989. doi: 10.1182/blood-2018-01-826495. Epub 2018 Feb 28. No abstract available.

PMID:
29490923
38.

Eponychial lesions following bilateral upper extremity vascular composite allotransplantation: a case report.

Fallahian F, Molway D, Jadeja S, Clark R, Marty FM, Riella LV, Chandraker A, Talbot SG.

Case Reports Plast Surg Hand Surg. 2018 Feb 2;5(1):14-17. doi: 10.1080/23320885.2018.1431047. eCollection 2018.

39.

Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation.

Pandit A, Leblebjian H, Hammond SP, Laubach JP, Richardson PG, Baden LR, Marty FM, Issa NC.

Bone Marrow Transplant. 2018 Jul;53(7):942-945. doi: 10.1038/s41409-018-0112-x. Epub 2018 Feb 9.

PMID:
29426830
40.

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C.

N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6.

41.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H.

Oncologist. 2017 Nov;22(11):1413. doi: 10.1634/theoncologist.2016-0298erratum. No abstract available.

42.

Seasonal Variability Precipitating Hand Transplant Rejection?

Lopdrup RG, Turk M, Win TS, Marty FM, Molway D, Tullius SG, Pomahac B, Talbot SG.

Transplantation. 2017 Oct;101(10):e313. doi: 10.1097/TP.0000000000001877. No abstract available.

PMID:
28930103
43.

Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.

Henrich TJ, Hobbs KS, Hanhauser E, Scully E, Hogan LE, Robles YP, Leadabrand KS, Marty FM, Palmer CD, Jost S, Körner C, Li JZ, Gandhi RT, Hamdan A, Abramson J, LaCasce AS, Kuritzkes DR.

J Infect Dis. 2017 Jul 15;216(2):254-262. doi: 10.1093/infdis/jix265.

44.

Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation.

Sultan AS, Zimering Y, Petruzziello G, Alyea EP 3rd, Antin JH, Soiffer RJ, Ho VT, Sonis ST, Woo SB, Marty FM, Treister NS.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Sep;124(3):253-260. doi: 10.1016/j.oooo.2017.06.003. Epub 2017 Jun 16.

PMID:
28823316
45.

Use of Multimodality Imaging in Diagnosing Invasive Fungal Diseases of the Heart.

DeFilippis EM, Cuddy S, Glass C, Priya S, Aghayev A, Mitchell RN, Marty FM, DiCarli MF, Blankstein R.

Circ Cardiovasc Imaging. 2017 Jun;10(6). pii: e006550. doi: 10.1161/CIRCIMAGING.117.006550. No abstract available.

PMID:
28576787
46.

Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation.

Prestes DP, Arbona E, Nevett-Fernandez A, Woolley AE, Ho VT, Koo S, Baden LR, Koreth J, Hammond SP, Issa NC, Marty FM.

Clin Infect Dis. 2017 Aug 1;65(3):510-513. doi: 10.1093/cid/cix325.

PMID:
28419210
47.

Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.

Kovanda LL, Marty FM, Maertens J, Desai AV, Lademacher C, Engelhardt M, Lu Q, Hope WW.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00101-17. doi: 10.1128/AAC.00101-17. Print 2017 Jun.

48.

Post-Babesiosis Warm Autoimmune Hemolytic Anemia.

Woolley AE, Montgomery MW, Savage WJ, Achebe MO, Dunford K, Villeda S, Maguire JH, Marty FM.

N Engl J Med. 2017 Mar 9;376(10):939-946. doi: 10.1056/NEJMoa1612165.

49.

Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid.

Hiraki LT, Feldman CH, Marty FM, Winkelmayer WC, Guan H, Costenbader KH.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1620-1626. doi: 10.1002/acr.23219. Epub 2017 Sep 21.

50.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H.

Oncologist. 2017 Mar;22(3):343-350. doi: 10.1634/theoncologist.2016-0298. Epub 2017 Feb 16. Review. Erratum in: Oncologist. 2017 Nov;22(11):1413.

Supplemental Content

Loading ...
Support Center